DCBLD2 Rekombinanter Antikörper
DCBLD2 Rekombinant Antikörper für WB, IHC, IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IP, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242604E8
Kat-Nr. : 85000-4-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
85000-4-PBS bindet in WB, IHC, IP, Indirect ELISA DCBLD2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | DCBLD2 fusion protein Ag32823 |
| Vollständiger Name | discoidin, CUB and LCCL domain containing 2 |
| Berechnetes Molekulargewicht | 775 aa, 89 kDa |
| Beobachtetes Molekulargewicht | 120 kDa |
| GenBank-Zugangsnummer | BC029658 |
| Gene symbol | DCBLD2 |
| Gene ID (NCBI) | 131566 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
DCBLD2, also known as ESDN or CLCP1, was first identified from human coronary arterial cells by a signal sequence trap method. DCBLD2 regulates proliferation, migration, and invasion in various tumors, including glioma, hypopharyngeal squamous cell carcinoma, and myxofibrosarcoma. The human DCBLD2 protein has a predicted molecular mass of ∼80 kDa based on its amino acid sequence, although it regularly displays an effective molecular mass of ∼130 kDa via SDS-PAGE (PMID: 30902898).













